title: Comments on Bang et al.: the impact of recombinant parathyroid hormone on malignancies and mortality: 7 years of experience based on nationwide Danish registers.
authors.affiliation: RTI Health Solutions, 3040 Cornwallis Road, Post Office Box 12194, Research Triangle Park, NC, 27709-2194, USA, eandrews@rti.org.
authors.forename: E B
authors.initials: EB
authors.lastname: Andrews
authors.forename: A W
authors.initials: AW
authors.lastname: Gilsenan
authors.forename: K D
authors.initials: KD
authors.lastname: Midkiff
authors.forename: D H
authors.initials: DH
authors.lastname: Harris
mesh_terms: D050071:Bone Density Conservation Agents / Q000009:adverse effects*; D005260:Female; D006801:Humans; D008297:Male; D009369:Neoplasms / Q000139:chemically induced*; D010281:Parathyroid Hormone / Q000009:adverse effects*
chemical_list: D050071:Bone Density Conservation Agents; D010281:Parathyroid Hormone